Dr. Paul La Porte
Claim this profileGSK Investigational Site
Area of expertise
Lung Cancer
Paul La Porte has run 5 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Paul La Porte has run 3 trials for Breast Cancer. Some of their research focus areas include:
Affiliated Hospitals
The Oncology Insitute Of Hope And Innovation
TOI Clinical Research
Clinical Trials Paul La Porte is currently running
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Recruiting
1 award
Phase 1 & 2
TSR-022
for Advanced Cancer
This trial is testing TSR-022, a new medicine that helps the immune system fight cancer by blocking a protein called TIM-3. TIM-3 has gained prominence as a potential candidate for cancer immunotherapy, where it has been shown that blocking TIM-3 with other treatments enhances the body's ability to fight tumors and suppress their growth. It targets patients with tumors, especially those who may not respond to standard treatments. The goal is to see if this medicine can help the immune system better attack cancer cells.
Recruiting
1 award
Phase 1
More about Paul La Porte
Clinical Trial Related
4 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Paul La Porte has experience with
- TSR-022
- Docetaxel
- Dostarlimab
- Cobolimab
- Enobosarm
- Exemestane
Breakdown of trials Paul La Porte has run
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul La Porte specialize in?
Paul La Porte focuses on Lung Cancer and Breast Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Paul La Porte currently recruiting for clinical trials?
Yes, Paul La Porte is currently recruiting for 2 clinical trials in Whittier California. If you're interested in participating, you should apply.
Are there any treatments that Paul La Porte has studied deeply?
Yes, Paul La Porte has studied treatments such as TSR-022, Docetaxel, Dostarlimab.
What is the best way to schedule an appointment with Paul La Porte?
Apply for one of the trials that Paul La Porte is conducting.
What is the office address of Paul La Porte?
The office of Paul La Porte is located at: GSK Investigational Site, Whittier, California 90603 United States. This is the address for their practice at the GSK Investigational Site.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.